LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2023-2024 Regular Session
House
Bills
HB8
US
US Federal House Bill HB8
US Federal 2023-2024 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2023-2024 Regular Session
US Federal House Bill HB8
Introduced
1/9/23
Refer
1/9/23
Refer
1/20/23
Caption
Drug Pricing Transparency and Accountability Act
Latest US HB8 Activity
View All Events: US 2023-2024 Regular Session HB8
Companion Bills
No companion bills found.
Previously Filed As
US SB477
relative to increasing transparency in the 340B Drug Pricing Program.
US SB3345
PBM Price Transparency and Accountability Act
US SB3751
Prescription Drug Supply Chain Pricing Transparency Act
US SB589
To Create The 340b Program Transparency Act; And To Amend The Law Concerning Transparency And Accountability For Certain 340b-covered Entities.
US HB685
AN ACT relating to the 340B Drug Pricing Program.
US HB07116
An Act Concerning Insurance Accountability And Transparency.
US SB1030
Prescription drug pricing; prohibiting certain action. Effective date.
US SB1030
Prescription drug pricing; prohibiting certain action. Effective date.
US SB5981
Revised for 2nd substitute: Concerning the 340B drug pricing program.
US HB7391
Community Health Center Drug Pricing Protection Act
Similar Bills
No similar bills found.